The non-viral drug delivery systems market size is estimated to be worth $7.1 billion and is expected to grow at CAGR of 13.8% during the forecast period. The anticipated market growth is accredited to the significant surge in demand across the regional and global markets for the products and services offered by the Non-Viral Drug Delivery Systems Market. The latest study provides readers with a granular analysis of the major developmental elements of the global market, potential business avenues, and the overall market dynamics. The report has been specially curated to offer a deep understanding of the competitive terrain of the global market, highlighting the leading market rivals, their market positions, product portfolios, gross revenue shares, profit margins, pricing analysis, sales network & distribution channels, and financial standing.

Type of Molecule Delivered

Small Molecules

Biologics

Type of Biologic Delivered

RNAi / mRNA

DNA Oligonucleotides

Antibodies

Proteins / Peptides

Type of Vehicle Used

Cell Penetrating Peptides

Extracellular Vesicles

Oligonucleotides

Nanoparticles

Polymers

Key Geographical Regions

North America

Europe

Asia

MENA

Latin America

Rest of the World

The latest research report specializes in the in-depth analysis of the macroeconomic and microeconomic factors affecting the Non-Viral Drug Delivery Systems Market development. The report also concentrates on the regulatory framework that is shaping the future of the global market. New and existing pricing structures, emerging application areas, and upcoming investment opportunities have also been detailed in the report. The report further studies the projected growth factors that are expected to influence the market dynamics over the forecast timeframe.

The study is inclusive of a comprehensive analysis of the commonly used marketing and promotional strategies adopted by the key market players. Taking into account the existing market development factors, historical events, and recent market trends, the study presents a balanced opinion on the future scenario of the Non-Viral Drug Delivery Systems Market. It thus supports its opinion by discussing the key corporate strategies, such as mergers & acquisitions, takeovers, joint ventures, and strategic alliances, used by the market players to strengthen their global footprint.

Research Methodology

Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Non-Viral Drug Delivery Systems Market.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

About Roots Analysis

Roots Analysisis a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Sales@rootsanalysis.com

Extensive research and development in this domain has led to the development and commercialization of several advanced needles such as safety needles and pen needles that are finer and less painful. These innovations have enhanced the use of needles across hospitals, diagnostic centers and homecare settings, making them vital for a wide range of therapeutic deliveries.

Key Report Takeaways

Currently, over 475 companies are engaged in the manufacturing and development of needles, with more than 30% of these players headquartered in China

Stainless steel has emerged as the preferred material for needle development due to its high tensile strength, durability and resistance to corrosion, thereby ensuring greater precision and safety in medical procedures

In pursuit of a competitive edge, stakeholders are actively upgrading their existing capabilities and enhancing their needle portfolios to meet evolving industry standards

Close to 40% of the deals have been inked in the last two years, demonstrating a considerable increase in partnership activity during this period; of these, close to 60% partnerships were international deals

Around 765 patents related to needles have been filed / granted by various industry and non-industry players to protect the intellectual property generated within this field

The market opportunity associated with needles is likely to witness an annualized growth rate of 6.1% till 2035 owing to the growing demand for injectable therapies

The global needles market is expected to be well distributed across different types of materials, modes of delivery and end users

Competitive Landscape of Global Needles Market

The global needles market landscape features over 475 needle providers. Overall, the market landscape of needles is well-fragmented, featuring the presence of very small, small, mid-sized, large, and very large device developers, which claim to have the required expertise and technologies to develop and commercialize needles for various purposes. It is interesting to highlight that most of these (~50%) needle providers are located in Asia-Pacific, followed by North America; prominent hubs in Asia-Pacific include China and India. Additionally, 8% of the needle providers offer both conventional as well as safety needles.

Global Needles Market Regional Outlook

Based on the geographical regions, the global needles market can be segmented into five major regions, including North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Led by the China, Asia-Pacific is anticipated to capture the majority share of the global needles market in 2025, and this trend is likely to remain unchanged during the forecast period.

Key industry players such as Greiner Bio-One International, Kawamoto, PENTAX Medical and Shimadzu are pivotal in shaping the market dynamics in this region. Additionally, the rising focus on expanding healthcare infrastructure with advanced treatments in North America is likely to be the reason to increase the application of needles in the region.

Latin America is likely to exhibit lucrative opportunities owing to the increasing prevalence of chronic diaseses. The preference towards innovative and advanced needles is one of the promising growth factors in Latin America.

Global Needles Market Key Players Profiled

Examples of key companies engaged in the global needles market (which are also profiled in this market report; the complete list of companies is available in the full report) include: Aleda Makina, B. Braun, BD, Biotronik, DALI Medical Devices, GEOTEK, Gerresheimer, Lars Medicare, MEDEREN Neotech, Medtronic, Novo Nordisk, Olympus America, Roche, SB-KAWASUMI LABORATORIES, Thermo Fisher Scientific, and Wuzhou Medical

Global Needles Market Segments

Based on research, Roots Analysis has segmented the Global Needles Market into Type of Needle based on Design, Type of Needle based on Purpose, Mode of Delivery, Type of Material, End Users, Geographical Regions and Leading Players

Global Needles Market, by Type of Needle based on Design

Conventional Needles

Safety Needles

Global Needles Market, by Type of Needle based on Purpose

Syringe Needles

Suture Needles

Pen Needles

Autoinjector Needles

Blood Collection Needles

Others

Global Needles Market, by Mode of Delivery

Subcutaneous

Intramuscular

Intravenous

Intradermal

Others

Global Needles Market, by Type of Material

Stainless Steel

Plastic

Others

Global Needles Market, by End Users

Hospitals and Clinics

Diagnostic Centers

Home Healthcare

Others

Global Needles Market, by Geographical Regions

North America (US, Canada and Mexico)

Europe (Germany, France, UK, Italy, Spain and Rest of Europe)

Asia-Pacific (China, India, Japan and Rest of Asia-Pacific)

Middle East and North Africa (Egypt, Saudi Arabia and UAE)

Latin America (Brazil and Argentina)

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact US

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com